Babak Shafiei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Babak Shafiei has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
Isa Neshandar Asli
Department of Nuclear Medicine, Taleghani Hospital, Shahid Beheshti University of Medical Sciences
11 shared publications- Majid Assadi
The Persian Gulf Nuclear Medicine Research Center, Department of Nuclear Medicine, Molecular Imaging, and Theranostics, Bushehr Medical University Hospital, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran
10 shared publications Hamid Javadi
Golestan Research Center of Gastroenterology and Hepatology (GRCGH), Golestan University of Medical Sciences (GUOMS)
8 shared publications- Faraj Tabeie
Department of Basic Sciences, School of Rehabilitation, Shahid Beheshti University of Medical Sciences, Tehran, Iran
7 shared publications - Iraj Nabipour
Bushehr University of Medical Sciences
5 shared publications - Mohsen Qutbi
Department of Nuclear Medicine, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4 shared publications
Latest Publications
- 6 May 2019
- Published by Georg Thieme Verlag KG in Nuklearmedizin-Nuclear Medicine
- Vol. 58 (03) , 249-257
Shifting paradigms in the management of pediatric differentiated thyroid cancer from static to dynamic risk stratification: a step forward toward precision medicine
Introduction This study aimed to assess the usefulness of a risk-adopted management system known as dynamic risk stratification (DRS) in comparison with the American (ATA) and European Thyroid Associations’ (ETA) risk classifications in the management of pediatric patients with differentiated thyroid cancer (DTC). Materials and Methods The current study included 50 pediatric patients with DTC who were treated with total or near total thyroidectomy and radioiodine ablation whose risk assessment was initially defined according to the ATA and ETA guidelines. During the two years after initial treatment, patients were reclassified according to their DRS. Results The study showed that the ability of the DRS system to predict the final outcome was superior to that of the ATA and ETA guidelines. The observed variance in predicting final outcome was 2.3 % for ETA, 14.8 % for ATA, and 83.4 % for DRS. In intermediate/high-risk patients, according to the ATA/ETA guidelines, an excellent response to initial therapy resulted in a noteworthy reduction (about 40 %) for detection of structural disease at the time of final follow-up. The risk of structural disease at the time of final follow-up was significantly higher in the structural incomplete response group (HR = 23.34, P = 0.00) and biochemical incomplete response group (HR = 13.83, P = 0.03) than in the excellent response group. Conclusion The data documented the significance of re-stratifying pediatric patients with DTC on the basis of the findings obtained at the time of or after their initial therapy (total thyroidectomy and radioiodine ablation), predominantly in the intermediate/high-risk patients. In addition, DRS helped to better modulate the later follow-up, excluding a large number of intermediate/high risk patients from needless intensive workups, allowing personalization of follow-up management.
- 6 May 2019
- Published by Georg Thieme Verlag KG in Nuklearmedizin-Nuclear Medicine
- Vol. 58 (03) , 249-257
Shifting paradigms in the management of pediatric differentiated thyroid cancer from static to dynamic risk stratification: a step forward toward precision medicine
Introduction This study aimed to assess the usefulness of a risk-adopted management system known as dynamic risk stratification (DRS) in comparison with the American (ATA) and European Thyroid Associations’ (ETA) risk classifications in the management of pediatric patients with differentiated thyroid cancer (DTC). Materials and Methods The current study included 50 pediatric patients with DTC who were treated with total or near total thyroidectomy and radioiodine ablation whose risk assessment was initially defined according to the ATA and ETA guidelines. During the two years after initial treatment, patients were reclassified according to their DRS. Results The study showed that the ability of the DRS system to predict the final outcome was superior to that of the ATA and ETA guidelines. The observed variance in predicting final outcome was 2.3 % for ETA, 14.8 % for ATA, and 83.4 % for DRS. In intermediate/high-risk patients, according to the ATA/ETA guidelines, an excellent response to initial therapy resulted in a noteworthy reduction (about 40 %) for detection of structural disease at the time of final follow-up. The risk of structural disease at the time of final follow-up was significantly higher in the structural incomplete response group (HR = 23.34, P = 0.00) and biochemical incomplete response group (HR = 13.83, P = 0.03) than in the excellent response group. Conclusion The data documented the significance of re-stratifying pediatric patients with DTC on the basis of the findings obtained at the time of or after their initial therapy (total thyroidectomy and radioiodine ablation), predominantly in the intermediate/high-risk patients. In addition, DRS helped to better modulate the later follow-up, excluding a large number of intermediate/high risk patients from needless intensive workups, allowing personalization of follow-up management.
- Open Access
- 22 April 2019
- Published by Georg Thieme Verlag KG in World Journal of Nuclear Medicine
- Vol. 18 (02) , 189-191
Jaffe–Campanacci syndrome: Any role for 99mTc-methylene diphosphonate bone and 99mTc-octreotide scans for evaluation of the disorder?
Jaffe–Campanacci syndrome (JCS) is a rare clinical disorder with almost unknown etiology. The main feature of this syndrome is skeletal involvement as nonossifying fibroma which may cause severe morbidity to these patients. X-ray imaging is the widely available modality for evaluation of skeleton, but radionuclide imaging modalities may have a role in workup. Herein, we present a case of JCS evaluated with99mTc-methylene diphosphonate bone and99mTc-octreotide scans for the extent of skeletal involvement. To the best of our knowledge, from over than 30 cases reported in the literature, no evaluation with radionuclide imaging has been done.
- 22 April 2019
- Published by Georg Thieme Verlag KG in World Journal of Nuclear Medicine
- Vol. 18 (02) , 189-191
Open AccessJaffe–Campanacci syndrome: Any role for 99mTc-methylene diphosphonate bone and 99mTc-octreotide scans for evaluation of the disorder?
Jaffe–Campanacci syndrome (JCS) is a rare clinical disorder with almost unknown etiology. The main feature of this syndrome is skeletal involvement as nonossifying fibroma which may cause severe morbidity to these patients. X-ray imaging is the widely available modality for evaluation of skeleton, but radionuclide imaging modalities may have a role in workup. Herein, we present a case of JCS evaluated with99mTc-methylene diphosphonate bone and99mTc-octreotide scans for the extent of skeletal involvement. To the best of our knowledge, from over than 30 cases reported in the literature, no evaluation with radionuclide imaging has been done.
- Open Access
- 31 January 2018
- Published by VM Media Group sp. z o.o in Nuclear Medicine Review
- Vol. 21 (1) , 50-52
Quantitation in Dextrocardia on myocardial perfusion imaging: how to perform quantitative analysis using Cedars-Sinai software
Dextrocardia, although a rare cardiac abnormality, carries the same risk for cardiac events as other people. SPECT Myocardial perfusion imaging is a potentially helpful diagnostic tool in patients with dextrocardia. Because of swapping of lateral and septal walls on SPECT slices, although visual analysis is possible, quantitation is substantially limited. Here, we introduce a simple practical method to make quantitative analysis feasible and accurate. Dextrocardia, although a rare cardiac abnormality, carries the same risk for cardiac events as other people. SPECT Myocardial perfusion imaging is a potentially helpful diagnostic tool in patients with dextrocardia. Because of swapping of lateral and septal walls on SPECT slices, although visual analysis is possible, quantitation is substantially limited. Here, we introduce a simple practical method to make quantitative analysis feasible and accurate.
- 31 January 2018
- Published by VM Media Group sp. z o.o in Nuclear Medicine Review
- Vol. 21 (1) , 50-52
Open AccessQuantitation in Dextrocardia on myocardial perfusion imaging: how to perform quantitative analysis using Cedars-Sinai software
Dextrocardia, although a rare cardiac abnormality, carries the same risk for cardiac events as other people. SPECT Myocardial perfusion imaging is a potentially helpful diagnostic tool in patients with dextrocardia. Because of swapping of lateral and septal walls on SPECT slices, although visual analysis is possible, quantitation is substantially limited. Here, we introduce a simple practical method to make quantitative analysis feasible and accurate. Dextrocardia, although a rare cardiac abnormality, carries the same risk for cardiac events as other people. SPECT Myocardial perfusion imaging is a potentially helpful diagnostic tool in patients with dextrocardia. Because of swapping of lateral and septal walls on SPECT slices, although visual analysis is possible, quantitation is substantially limited. Here, we introduce a simple practical method to make quantitative analysis feasible and accurate.
- 1 December 2017
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 42 (12) , 952-957
An Unexpected and Less Recognized Altered Distribution on Bone Scintigraphy; Possibility of 99mTc-Dextrose Complex as a Cause
Optimal performance of diagnostic tests and correct interpretation depend on multiple factors, one of which is proper radiopharmaceutical preparation. Unwanted impurities result in altered distribution of radiopharmaceuticals and then poor-quality or uninterpretable studies. Therefore, following the reconstitution steps according to standard and validated protocols by the technologist is mandatory. Here, we present 2 cases with unexpected and less recognized distribution of 99mTc–methylene diphosphonate on bone scintigraphy.
- 1 December 2017
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 42 (12) , 952-957
An Unexpected and Less Recognized Altered Distribution on Bone Scintigraphy; Possibility of 99mTc-Dextrose Complex as a Cause
Optimal performance of diagnostic tests and correct interpretation depend on multiple factors, one of which is proper radiopharmaceutical preparation. Unwanted impurities result in altered distribution of radiopharmaceuticals and then poor-quality or uninterpretable studies. Therefore, following the reconstitution steps according to standard and validated protocols by the technologist is mandatory. Here, we present 2 cases with unexpected and less recognized distribution of 99mTc–methylene diphosphonate on bone scintigraphy.
- 24 November 2017
- Published by Oxford University Press (OUP) in Radiation Protection Dosimetry
- Vol. 179 (2) , 151-157
POPULATION RADIATION EXPOSURE FROM DIAGNOSTIC NUCLEAR MEDICINE PROCEDURES IN TEHRAN 2011–14; TRENDS IN THE LAST 3 DECADES
This study represents an update of Tehran population exposure from the diagnostic nuclear medicine procedures and the annual collective effective dose during 2011–14. The diagnostic nuclear medicine procedures data were collected from 58 out of 60 nuclear medicine centers in Tehran and were composed of the type and frequency of diagnostic examinations, radiopharmaceuticals used, administered activities, and age distribution of the patients. The annual number of examinations per 1000 population increased from 13.73 in 2011 to 22.59 in 2014 with an increase of 64.53% during 4 years. Most frequent examinations were cardiac (71.05%), bone (9.80%) and thyroid (7.26%) averaged over the 5 years. The collective effective dose increased from 807.74 person-Sv in 2011 to 1413.81 person-Sv in 2014. The effective dose per capita increased from 44.06 μSv in 2011 to 120.91 μSv in 2014, could be because of 70% increase of examinations, but ~3.42% increase in the population of Tehran.
- 24 November 2017
- Published by Oxford University Press (OUP) in Radiation Protection Dosimetry
- Vol. 179 (2) , 151-157
POPULATION RADIATION EXPOSURE FROM DIAGNOSTIC NUCLEAR MEDICINE PROCEDURES IN TEHRAN 2011–14; TRENDS IN THE LAST 3 DECADES
This study represents an update of Tehran population exposure from the diagnostic nuclear medicine procedures and the annual collective effective dose during 2011–14. The diagnostic nuclear medicine procedures data were collected from 58 out of 60 nuclear medicine centers in Tehran and were composed of the type and frequency of diagnostic examinations, radiopharmaceuticals used, administered activities, and age distribution of the patients. The annual number of examinations per 1000 population increased from 13.73 in 2011 to 22.59 in 2014 with an increase of 64.53% during 4 years. Most frequent examinations were cardiac (71.05%), bone (9.80%) and thyroid (7.26%) averaged over the 5 years. The collective effective dose increased from 807.74 person-Sv in 2011 to 1413.81 person-Sv in 2014. The effective dose per capita increased from 44.06 μSv in 2011 to 120.91 μSv in 2014, could be because of 70% increase of examinations, but ~3.42% increase in the population of Tehran.
- Open Access
- 1 June 2017
- Vol. 19 (2) , 184-193
Radioactive Iodine Therapy and Glucose Tolerance
Radioactive iodine therapy is commonly used as an adjuvant therapy in follicular and papillary thyroid carcinoma (PTC) and in the treatment of Graves' disease (GD). The basis of this therapy is the accumulation of radioactive iodine by the sodium-iodide symporter (NIS) in the thyroid gland. Expression of NIS by extrathyroidal tissues such as islets of pancreas has been reported. Radioactive iodine uptake by pancreatic beta-cells can potentially damage these cells. In this study, we discuss the possible associations between radioactive iodine and glucose intolerance. Overall, radioactive iodine uptake by the pancreas may damage beta-cells and predispose patients to glucose intolerance or type 2 diabetes, particularly in patients exposed to radioactive iodine therapy following total thyroidectomy. Further studies are needed to clarify and confirm this association.
- 1 June 2017
- Vol. 19 (2) , 184-193
Open AccessRadioactive Iodine Therapy and Glucose Tolerance
Radioactive iodine therapy is commonly used as an adjuvant therapy in follicular and papillary thyroid carcinoma (PTC) and in the treatment of Graves' disease (GD). The basis of this therapy is the accumulation of radioactive iodine by the sodium-iodide symporter (NIS) in the thyroid gland. Expression of NIS by extrathyroidal tissues such as islets of pancreas has been reported. Radioactive iodine uptake by pancreatic beta-cells can potentially damage these cells. In this study, we discuss the possible associations between radioactive iodine and glucose intolerance. Overall, radioactive iodine uptake by the pancreas may damage beta-cells and predispose patients to glucose intolerance or type 2 diabetes, particularly in patients exposed to radioactive iodine therapy following total thyroidectomy. Further studies are needed to clarify and confirm this association.
- 10 March 2017
- Published by Springer Nature in Endocrine
- Vol. 56 (2) , 399-407
High dose of radioactive iodine per se has no effect on glucose metabolism in thyroidectomized rats
- 10 March 2017
- Published by Springer Nature in Endocrine
- Vol. 56 (2) , 399-407
High dose of radioactive iodine per se has no effect on glucose metabolism in thyroidectomized rats
- Open Access
- 1 January 2016
- Published by Scientific Scholar in Indian Journal of Nuclear Medicine
- Vol. 31 (2) , 119-22
An update on radiation absorbed dose to patients from diagnostic nuclear medicine procedures in Tehran: A study on four academic centers
Purpose: Use of radiopharmaceuticals for diagnostic nuclear medicine procedures is one of the main sources of radiation exposure. We performed this study with respect to the rapid growth in nuclear medicine in Iran and lack of updated statistics. Materials and Methods: The data were obtained for all active Nuclear Medicine Centers affiliated to Shahid Beheshti University of Medical Sciences during 2009 and 2010. Results: The most frequently performed procedures were bone (30.16%), cardiac (28.96%), renal (17.97%), and thyroid (7.93%) scans. There was a significant decrease in the number of thyroid scintigraphies with 131 I and 99m Tc-sulfur colloid liver/spleen scans and tremendous increase in the frequencies of cardiac and bone scintigraphies compared to one decade ago. Conclusion: Compared to previous studies, there were striking changes in trends of diagnostic nuclear medicine procedures in Tehran. This field is still evolving in the country, and this trend will further change with the introduction of positron emission tomography scanners in future.
- 1 January 2016
- Published by Scientific Scholar in Indian Journal of Nuclear Medicine
- Vol. 31 (2) , 119-22
Open AccessAn update on radiation absorbed dose to patients from diagnostic nuclear medicine procedures in Tehran: A study on four academic centers
Purpose: Use of radiopharmaceuticals for diagnostic nuclear medicine procedures is one of the main sources of radiation exposure. We performed this study with respect to the rapid growth in nuclear medicine in Iran and lack of updated statistics. Materials and Methods: The data were obtained for all active Nuclear Medicine Centers affiliated to Shahid Beheshti University of Medical Sciences during 2009 and 2010. Results: The most frequently performed procedures were bone (30.16%), cardiac (28.96%), renal (17.97%), and thyroid (7.93%) scans. There was a significant decrease in the number of thyroid scintigraphies with 131 I and 99m Tc-sulfur colloid liver/spleen scans and tremendous increase in the frequencies of cardiac and bone scintigraphies compared to one decade ago. Conclusion: Compared to previous studies, there were striking changes in trends of diagnostic nuclear medicine procedures in Tehran. This field is still evolving in the country, and this trend will further change with the introduction of positron emission tomography scanners in future.
- 1 July 2014
- Vol. 18 (13) , 1925-1929
Pathological evaluation of differentiated thyroid cancer in patients with positive serum thyroglobulin and negative iodine scan
OBJECTIVE: There is no investigation that emphasizes the pathology of DTC (differentiated thyroid cancer) patients with positive Tg and negative iodine scan. The present study was performed to assess the pathology of these patients. MATERIALS AND METHODS: In this retrospective study, the records of 500 patients with differentiated thyroid cancer between June 2005 and November 2011 were assessed, and those patients who had elevated serum thyroglobulin (Tg) with a negative whole body I-131 scan (Tg+/WBS-) were included in the study. Patients were followed for clinical and pathological findings of thyroid cancer, including type, variant, local invasion and cervical lymph node metastasis, and serum Tg, TgAb, and TSH levels. RESULTS: A total of 38 patients, including 31 (81.6%) females and 7 (18.4) males with a mean age of 44.2 +/- 15.6 years (range, 14 to 77 yrs) took part in the study. All 38 patients had the papillary type of differentiated thyroid cancer (PCDTC), and none had the follicular type of differentiated thyroid cancer (FCDTC). For the variant type of PTC in 16 patients, it was found that 7 were classic type (43.8%), 7 were follicular type (43.8%), and 2 were tall cell (12.4%) for papillary thyroid cancer. In 22 patients no distinct variant had been reported. CONCLUSIONS: This report demonstrated that all of the 38 patients were PTC (100%), which is different from other previous studies. It may be concluded that the overall pathologic subtypes changes of DTC could mainly be due to the iodine fortification program in various geographic regions. The relationship between DTC pathologic subtypes and frequency of Tg+/WBS-condition was difficult to assess in this work. Therefore, further studies are required to evaluate this issue.
- 1 July 2014
- Vol. 18 (13) , 1925-1929
Pathological evaluation of differentiated thyroid cancer in patients with positive serum thyroglobulin and negative iodine scan
OBJECTIVE: There is no investigation that emphasizes the pathology of DTC (differentiated thyroid cancer) patients with positive Tg and negative iodine scan. The present study was performed to assess the pathology of these patients. MATERIALS AND METHODS: In this retrospective study, the records of 500 patients with differentiated thyroid cancer between June 2005 and November 2011 were assessed, and those patients who had elevated serum thyroglobulin (Tg) with a negative whole body I-131 scan (Tg+/WBS-) were included in the study. Patients were followed for clinical and pathological findings of thyroid cancer, including type, variant, local invasion and cervical lymph node metastasis, and serum Tg, TgAb, and TSH levels. RESULTS: A total of 38 patients, including 31 (81.6%) females and 7 (18.4) males with a mean age of 44.2 +/- 15.6 years (range, 14 to 77 yrs) took part in the study. All 38 patients had the papillary type of differentiated thyroid cancer (PCDTC), and none had the follicular type of differentiated thyroid cancer (FCDTC). For the variant type of PTC in 16 patients, it was found that 7 were classic type (43.8%), 7 were follicular type (43.8%), and 2 were tall cell (12.4%) for papillary thyroid cancer. In 22 patients no distinct variant had been reported. CONCLUSIONS: This report demonstrated that all of the 38 patients were PTC (100%), which is different from other previous studies. It may be concluded that the overall pathologic subtypes changes of DTC could mainly be due to the iodine fortification program in various geographic regions. The relationship between DTC pathologic subtypes and frequency of Tg+/WBS-condition was difficult to assess in this work. Therefore, further studies are required to evaluate this issue.
- 1 March 2014
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 39 (3) , 232-236
The Electromagnetic Interference of Mobile Phones on the Function of a γ-Camera
Purpose The aim of the present study is to evaluate whether or not the electromagnetic field generated by mobile phones interferes with the function of a SPECT γ-camera during data acquisition. Methods We tested the effects of 7 models of mobile phones on 1 SPECT γ-camera. The mobile phones were tested when making a call, in ringing mode, and in standby mode. The γ-camera function was assessed during data acquisition from a planar source and a point source of 99mTc with activities of 10 mCi and 3 mCi, respectively. A significant visual decrease in count number was considered to be electromagnetic interference (EMI). Results The percentage of induced EMI with the γ-camera per mobile phone was in the range of 0% to 100%. The incidence of EMI was mainly observed in the first seconds of ringing and then mitigated in the following frames. Conclusions Mobile phones are portable sources of electromagnetic radiation, and there is interference potential with the function of SPECT γ-cameras leading to adverse effects on the quality of the acquired images.
- 1 March 2014
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 39 (3) , 232-236
The Electromagnetic Interference of Mobile Phones on the Function of a γ-Camera
Purpose The aim of the present study is to evaluate whether or not the electromagnetic field generated by mobile phones interferes with the function of a SPECT γ-camera during data acquisition. Methods We tested the effects of 7 models of mobile phones on 1 SPECT γ-camera. The mobile phones were tested when making a call, in ringing mode, and in standby mode. The γ-camera function was assessed during data acquisition from a planar source and a point source of 99mTc with activities of 10 mCi and 3 mCi, respectively. A significant visual decrease in count number was considered to be electromagnetic interference (EMI). Results The percentage of induced EMI with the γ-camera per mobile phone was in the range of 0% to 100%. The incidence of EMI was mainly observed in the first seconds of ringing and then mitigated in the following frames. Conclusions Mobile phones are portable sources of electromagnetic radiation, and there is interference potential with the function of SPECT γ-cameras leading to adverse effects on the quality of the acquired images.